This differential sensitivity likely reflects underlying tumor biology: BRCA1-associated cancers are more frequently triple-negative and characterized by a high proliferative index, genomic instability, and basal-like transcriptional profiles, all features linked to heightened chemosensitivity. This evidence concerns the gene BRCA1 and neoplasm.